To determine if ADT-094 can suppress Wnt/β-catenin signaling by a mechanism involving PKG activation, PKG activation and β-catenin levels were measured in the same lysates from colon tumor cells treated with ADT-094. The gene discussed is PRKG1; the disease is colonic neoplasm.